Skip to main content

Activist Elliott makes inroads at Catalent to build value. Here’s what could happen next

Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.